Zyla life sciences (EGLT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Feb'19Jan'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Assets
Current assets:
Cash and cash equivalents

14,541

11,965

18,594

12,054

10,387

17,047

36,785

35,323

34,248

37,829

33,679

31,090

37,750

29,868

26,987

44,355

46,622

35,021

34,167

46,665

77,158

57,666

53,887

52,738

59,725

69,259

77,450

15,700

Marketable securities, available for sale

-

-

-

-

-

4,994

4,994

4,988

15,966

32,178

40,786

59,953

64,308

57,627

78,357

42,471

54,592

68,647

89,451

99,042

91,911

50,764

-

-

-

-

-

-

Accounts receivable, net

31,062

25,697

26,578

21,217

39,944

4,141

4,141

8,006

10,841

9,083

14,983

4,120

5,607

5,107

5,410

1,108

3,890

820

829

295

-

-

-

-

-

-

-

-

Related party receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

57

102

537

10,470

679

186

345

141

-

Inventory

10,281

9,049

9,538

14,585

23,276

33,838

2,299

2,639

3,039

3,183

2,113

3,225

1,835

1,949

1,511

1,700

1,487

1,742

2,137

1,837

3,552

3,887

2,621

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

-

-

-

-

-

577

275

-

-

-

-

-

-

Prepaid expenses and other current assets

3,445

4,102

1,571

2,181

3,258

3,943

2,497

2,715

848

1,539

2,232

2,672

1,399

1,367

1,378

2,537

1,867

1,142

1,616

1,295

1,374

378

1,089

698

829

526

659

1,812

Other receivables

878

815

-

160

-

133

133

846

991

889

911

893

1,153

1,190

1,049

1,001

1,287

1,089

2,217

1,047

922

931

896

1,011

213

230

231

231

Total current assets

60,207

51,628

56,281

50,197

76,865

64,096

50,849

54,517

65,933

84,701

94,704

101,953

112,052

97,108

114,889

93,172

109,745

108,461

130,417

150,238

175,596

114,438

68,963

55,126

60,953

70,360

78,481

17,743

Intangible assets, net

106,985

110,482

113,980

117,477

120,974

123,306

4,109

4,281

4,816

5,466

6,091

6,583

7,076

7,520

7,882

8,350

8,921

9,405

9,942

10,380

10,993

11,497

9,536

184

192

208

209

209

Restricted cash

400

400

400

400

400

400

400

400

400

400

400

400

400

400

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

3,118

3,316

3,513

3,752

3,941

4,074

1,027

1,059

1,158

8,565

9,252

9,911

10,607

11,318

11,857

12,709

13,584

12,268

11,310

7,801

4,106

4,330

4,279

4,417

2,430

2,476

2,292

2,378

Right of use assets

2,479

2,672

2,885

1,577

1,745

1,854

1,854

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

53,917

58,747

58,747

58,747

58,747

58,747

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,367

-

-

-

-

-

Deposits and other assets

2,373

3,142

3,242

3,423

2,151

1,676

1,676

1,676

308

848

851

1,011

1,052

1,677

705

627

1,823

3,440

3,570

3,997

3,263

562

693

843

2,297

2,087

182

33

Total assets

229,479

230,387

239,048

235,573

264,823

254,153

59,915

61,933

72,615

99,980

111,298

119,858

131,187

118,023

135,333

114,858

134,073

133,574

155,239

172,416

193,958

130,827

86,838

60,570

65,872

75,131

81,164

20,363

Liabilities and stockholders’ equity
Current liabilities:
Related party senior convertible debt, net of discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,209

Accounts payable

23,101

12,752

15,807

7,011

11,569

8,339

9,839

8,561

6,708

8,758

10,142

10,160

5,626

3,183

6,598

2,392

5,713

6,112

5,087

7,417

3,469

3,723

3,086

4,209

1,285

2,507

1,378

1,046

Accrued expenses

55,310

50,357

49,625

49,602

58,925

46,800

26,617

24,584

27,001

27,949

25,143

16,104

17,972

21,280

15,033

18,147

13,933

9,026

9,573

7,799

5,103

5,504

4,434

2,554

2,874

1,551

680

1,755

Deferred revenue

-

-

-

0

-

-

-

-

0

0

0

7,456

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

8,759

6,188

6,175

3,975

4,910

7,182

8,374

10,128

13,718

15,108

15,953

588

551

551

551

557

Debt - current, net

7,797

8,177

6,990

4,428

2,635

1,492

-

-

129,372

22,386

1,099

1,081

547

624

428

381

133

6,809

5,045

3,320

3,970

2,616

1,294

-

-

-

-

-

Acquisition-related contingent consideration

5,825

3,500

2,700

2,500

1,200

1,200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

2,833

5,000

8,166

8,166

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License fee payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,500

2,500

2,500

-

-

-

-

-

Other current liabilities

1,008

985

976

994

1,043

1,030

1,030

-

-

-

-

-

-

-

-

-

500

383

251

-

68

118

53

78

76

74

80

55

Total current liabilities

93,041

75,771

76,098

64,535

75,372

58,861

37,538

33,145

163,081

61,926

41,384

42,967

41,070

31,275

28,234

24,895

25,189

29,512

28,330

28,664

28,828

29,569

27,320

7,429

4,786

4,683

2,689

20,622

Debt - non-current portion, net

91,346

91,710

92,630

93,247

92,957

93,371

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related contingent consideration

14,475

14,400

15,600

15,200

13,800

13,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt - non-current portion, net

-

-

-

-

-

-

-

-

1,221

78,620

99,166

98,890

126,161

124,680

123,380

83,711

82,070

51,439

51,959

52,442

50,647

50,758

13,215

-

-

-

-

-

Deferred income tax liability

-

-

23

24

24

-

-

-

25

1,005

946

26

25

24

23

23

304

662

900

1,084

27

27

49

25

22

22

21

22

Credit agreement

4,138

4,050

3,965

3,953

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - non-current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,508

16,703

18,029

8,855

9,041

9,188

9,334

9,592

Derivative liability

-

-

-

-

-

-

-

-

-

1,153

2,167

16,623

-

-

-

12

14

3

46

656

1,097

1,689

-

-

-

-

-

-

Other liabilities

1,783

2,065

2,329

935

1,165

1,360

1,463

560

583

634

685

727

770

814

849

891

941

1,504

1,269

348

185

120

57

-

-

-

-

-

Total liabilities

204,783

187,996

190,645

177,894

188,318

167,216

39,025

33,705

-

-

-

159,233

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities subject to compromise

-

-

-

-

-

-

138,884

139,588

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

-

-

-

-

-

-

-

-

164,910

143,338

144,348

-

168,026

156,793

152,486

109,532

108,518

83,120

82,504

83,194

97,292

98,866

58,670

16,309

13,849

13,893

12,044

30,236

Commitments and contingencies (Note 17)

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

-

-

0

-

-

-

0

0

0

0

-

Redeemable convertible series preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,957

Stockholders’ equity:
Common stock--$0.001 par value; 100,000,000 shares authorized; 9,591,957 shares issued and outstanding at March 31, 2020: and 9,437,883 shares issued and outstanding at December 31, 2019

10

9

9

9

9

9

55

55

53

52

49

46

43

26

26

25

25

25

25

25

25

17

17

17

17

17

17

13

Additional paid-in capital

89,503

89,027

88,817

87,806

86,988

86,928

276,880

276,569

275,680

273,379

271,551

254,871

258,989

238,315

233,941

230,379

228,735

226,808

225,099

223,784

224,034

141,964

122,471

121,028

120,014

118,017

114,189

7,431

Accumulated other comprehensive income (loss)

62

-5

-7

-10

-9

-

866

869

912

926

1,102

1,008

868

683

194

100

603

495

705

-41

389

401

-986

-171

139

1,176

1,229

1,125

Accumulated deficit

-64,879

-46,640

-40,416

-30,126

-10,483

-

-395,795

-388,853

-368,940

-317,715

-305,752

-295,300

-296,739

-277,794

-251,314

-225,178

-203,808

-176,874

-153,094

-134,546

-127,782

-110,421

-93,334

-76,613

-68,147

-57,972

-46,315

-33,399

Total stockholders' equity

24,696

42,391

48,403

57,679

76,505

86,937

-117,994

-111,360

-92,295

-43,358

-33,050

-39,375

-36,839

-38,770

-17,153

5,326

25,555

50,454

72,735

89,222

96,666

31,961

28,168

44,261

52,023

61,238

69,120

-24,830

Total liabilities and stockholders’ equity

229,479

230,387

239,048

235,573

264,823

254,153

59,915

61,933

72,615

99,980

111,298

119,858

131,187

118,023

135,333

114,858

134,073

133,574

155,239

172,416

193,958

130,827

86,838

60,570

65,872

75,131

81,164

20,363